Nanobiotix is a clinical-stage biotechnology company based in Paris, France. It develops nanoparticle-based approaches intended to improve the effectiveness of radiotherapy in cancer treatment. Its main programme uses hafnium oxide nanoparticles, given as an injectable product, to amplify the radiation dose inside tumour cells while sparing surrounding healthy tissue. The company works with hospital clinicians and research partners on studies in several tumour types, and it also pursues oncology programmes built on its nanoparticle platform.
Nanobiotix S.A trades under the code NANO on the Euronext Paris in France, with its price quoted in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #437 of 625 on the Euronext Paris · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for France yet.
TrendWeak
33/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-34.7%
From 52-week high-59.2%
MomentumWeak
38/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-45.8%
6-month return-34.5%
12-month, skipping last month55.4%
Stability (higher is calmer)Weak
19/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)77.0%
Worst drawdown, 1 year (smaller is calmer)-59.2%
LiquidityStrong
87/100
Trades actively.
See the numbers →
Avg daily value traded4.66M EUR
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for France when fundamentals data for this market is added. All France stocks.
52-wk range 13.10 – 47.66Daily closes, split-adjusted
Signals
50-day average29.69
200-day average28.85
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.61
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
2 bullish · 1 neutral · 9 bearish
Monthly
Neutral
3 bullish · 1 neutral · 4 bearish
Moving averages (daily)
SMA 10
20.45
Bearish
EMA 10
20.74
Bearish
SMA 20
23.79
Bearish
EMA 20
23.21
Bearish
SMA 50
29.69
Bearish
EMA 50
27.46
Bearish
SMA 100
31.10
Bearish
EMA 100
29.22
Bearish
SMA 200
28.85
Bearish
EMA 200
27.41
Bearish
Oscillators (daily)
RSI (14)
21.07
Bullish
MACD (12, 26)
-3.16
Bearish
Momentum (12)
-25.79
Bearish
Stochastic %K (14)
4.10
Bullish
Williams %R (14)
-95.90
Bullish
CCI (20)
-97.22
Neutral
Pivot points (classic, last session)
S3
18.01
S2
18.24
S1
18.54
Pivot
18.77
R1
19.07
R2
19.30
R3
19.60
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
